Comparative effectiveness of first-line palbociclib plus letrozole versus letrozole alone for HR+/HER2− metastatic breast cancer in US real-world clinical practice

BACKGROUND: Findings from randomized clinical trials may have limited generalizability to patients treated in routine clinical practice. This study examined the effectiveness of first-line palbociclib plus letrozole versus letrozole alone on survival outcomes in patients with hormone receptor–positi...

Descripción completa

Detalles Bibliográficos
Autores principales: DeMichele, Angela, Cristofanilli, Massimo, Brufsky, Adam, Liu, Xianchen, Mardekian, Jack, McRoy, Lynn, Layman, Rachel M., Emir, Birol, Torres, Mylin A., Rugo, Hope S., Finn, Richard S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7989035/
https://www.ncbi.nlm.nih.gov/pubmed/33761995
http://dx.doi.org/10.1186/s13058-021-01409-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7989035/
https://www.ncbi.nlm.nih.gov/pubmed/33761995
http://dx.doi.org/10.1186/s13058-021-01409-8

Ejemplares similares